KR20150051751A - Composition for treating hair or scalp to prevent hair loss - Google Patents
Composition for treating hair or scalp to prevent hair loss Download PDFInfo
- Publication number
- KR20150051751A KR20150051751A KR1020130133649A KR20130133649A KR20150051751A KR 20150051751 A KR20150051751 A KR 20150051751A KR 1020130133649 A KR1020130133649 A KR 1020130133649A KR 20130133649 A KR20130133649 A KR 20130133649A KR 20150051751 A KR20150051751 A KR 20150051751A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- extract
- composition
- scalp
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 210000004761 scalp Anatomy 0.000 title claims abstract description 25
- 201000004384 Alopecia Diseases 0.000 title abstract description 16
- 230000003676 hair loss Effects 0.000 title abstract description 12
- 208000024963 hair loss Diseases 0.000 title abstract description 12
- 210000004209 hair Anatomy 0.000 title description 10
- 239000000284 extract Substances 0.000 claims abstract description 60
- 244000018633 Prunus armeniaca Species 0.000 claims abstract description 24
- 235000009827 Prunus armeniaca Nutrition 0.000 claims abstract description 24
- 241000411851 herbal medicine Species 0.000 claims abstract description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 19
- 201000010099 disease Diseases 0.000 claims abstract description 18
- 230000003658 preventing hair loss Effects 0.000 claims abstract description 15
- 235000020234 walnut Nutrition 0.000 claims description 29
- 240000007049 Juglans regia Species 0.000 claims description 23
- 235000009496 Juglans regia Nutrition 0.000 claims description 23
- 244000236655 Diospyros kaki Species 0.000 claims description 14
- 238000000855 fermentation Methods 0.000 claims description 14
- 230000004151 fermentation Effects 0.000 claims description 14
- 235000011511 Diospyros Nutrition 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 9
- 241000758791 Juglandaceae Species 0.000 claims description 8
- 240000003291 Armoracia rusticana Species 0.000 claims description 6
- 235000011330 Armoracia rusticana Nutrition 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 241000269821 Scombridae Species 0.000 claims description 4
- 235000020640 mackerel Nutrition 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 2
- 241001494246 Daphnia magna Species 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 210000005070 sphincter Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 abstract description 6
- 208000008742 seborrheic dermatitis Diseases 0.000 abstract description 6
- 230000003779 hair growth Effects 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 description 13
- 239000002994 raw material Substances 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 239000006210 lotion Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000006071 cream Substances 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000010355 oscillation Effects 0.000 description 4
- 241001474374 Blennius Species 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 3
- 241000863480 Vinca Species 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- -1 etc. Substances 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- MPIBOQKDJNGGSK-BPNCWPANSA-N (1ar,4as,8as)-4a,8,8-trimethyl-1a,5,6,7-tetrahydro-1h-cyclopropa[j]naphthalen-2-one Chemical compound C1=CC(=O)[C@@H]2C[C@@]22C(C)(C)CCC[C@]21C MPIBOQKDJNGGSK-BPNCWPANSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960003473 androstanolone Drugs 0.000 description 2
- 230000003656 anti-hair-loss Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ZDHCZVWCTKTBRY-UHFFFAOYSA-N 12-hydroxylauric acid Chemical compound OCCCCCCCCCCCC(O)=O ZDHCZVWCTKTBRY-UHFFFAOYSA-N 0.000 description 1
- UGAGPNKCDRTDHP-UHFFFAOYSA-N 16-hydroxyhexadecanoic acid Chemical compound OCCCCCCCCCCCCCCCC(O)=O UGAGPNKCDRTDHP-UHFFFAOYSA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N 3‐isothujone Chemical compound CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- 235000006667 Aleurites moluccana Nutrition 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000008597 Diospyros kaki Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 240000002924 Platycladus orientalis Species 0.000 description 1
- 241000723554 Pontia occidentalis Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003778 catagen phase Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 210000001136 chorion Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000000332 coumarinyl group Chemical class O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- 210000003785 decidua Anatomy 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- VVEKCQAFOLKNKB-UHFFFAOYSA-N emodine Natural products C1=CC=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O VVEKCQAFOLKNKB-UHFFFAOYSA-N 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 208000027700 hepatic dysfunction Diseases 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000003797 telogen phase Effects 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229930007110 thujone Natural products 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 탈모 방지 및 두피질환 치료용 조성물에 관한 것으로, 살구씨, 하수오, 측백엽 및 호두와 같은 생약 추출물과 호두 외과피 추출물 발효액의 복합 작용으로 탈모 방지, 모발 성장 촉진 및 두피 질환의 치료에 효과가 있는 조성물에 관한 것이다.
본 발명의 조성물은 탈모의 감소 및 지루성 피부염의 증상을 개선하는 효과가 우수하므로, 두피에 나타나는 질환의 치료 등에 널리 적용될 수 있다. 또한 끈적임과 냄새가 상대적으로 적어, 사용자의 거부감을 최소화할 수 있다. The present invention relates to a composition for preventing hair loss and treating a scalp disease, and is effective for preventing hair loss, promoting hair growth, and treating scalp disease by the combined action of herbal medicine extracts such as apricot seeds, ≪ / RTI >
The composition of the present invention is excellent in the effect of alleviating hair loss and improving the symptoms of seborrheic dermatitis, so that it can be widely applied to the treatment of diseases appearing on the scalp. Also, the stickiness and the smell are relatively small, and the user's sense of rejection can be minimized.
Description
본 발명은 탈모 방지 및 두피질환 치료용 조성물에 관한 것으로, 살구씨, 하수오, 측백엽 및 호두와 같은 생약 추출물과 호두 외과피 추출물 발효액의 복합 작용으로 탈모 방지, 모발 성장 촉진 및 두피 질환의 치료에 효과가 있는 조성물에 관한 것이다.
The present invention relates to a composition for preventing hair loss and treating a scalp disease, and is effective for preventing hair loss, promoting hair growth, and treating scalp disease by the combined action of herbal medicine extracts such as apricot seeds, ≪ / RTI >
인체의 모발은 약 10만 ~ 15만개 정도이며, 각각의 모발은 성장기(anagen), 퇴행기(catagen), 휴지기(telogen)를 거치며 성장하고, 탈락한다. 각 단계를 거쳐 순환하는데 탈락 과정을 거쳐 순환주기가 완료되는 기간은 3 - 6년이 소요된다. 일반적으로 탈모증은 일일 두피에서 탈락하는 모발의 숫자가 새로 만들어 지는 숫자보다 많을 경우 급격히 또는 완만히 머리카락의 숫자가 감소하는 현상이다.The human body has about 100,000 to 150,000 hairs, and each hair grows through anagen, catagen, and telogen, and falls off. It takes 3 to 6 years to complete the circulation cycle after eliminating the circulation through each step. In general, alopecia is a phenomenon in which the number of hair dropping from the scalp per day is suddenly or gently reduced when the number of hair is larger than the number of new hair.
탈모의 원인은 다이하이드로데스토스테론(dihydrotestosteroe)이 두피에서 과잉 생성되어 모낭의 기능이 저하되는 것, 혈액순환 장애, 영양 불균형, 두피의 화학물질에 의한 스트레스, 심리적인 스트레스, 질병, 및 지루성 피부염 등 다양한 두피 질환이 복합적으로 작용하여 두피의 기능을 저하시키는 것이다.The cause of hair loss is caused by excessive production of dihydrotestosterone in the scalp, resulting in deterioration of hair follicle function, blood circulation disorder, nutritional imbalance, stress caused by chemical substances in scalp, psychological stress, disease, and seborrheic dermatitis And a variety of other scalp disorders such as the function of the scalp is to reduce the function.
남성호르몬 중의 하나인 테스토스테론(testosterone)은 5α-리덕타제라는 효소의 작용에 의해 다이하이드로데스토스테론(dihydrotestosteroe)으로 전환되고, 이 전환체가 탈모를 촉진하는 것으로 알려짐에 따라, 다이하이드로데스토스테론의 생성을 억제하는 효과를 통해 탈모를 방지하는 제품이 개발되었다. 이런 관점에서 남성의 전립선 치료제로 사용되어 오던 피나스테라이드(finasteride)라는 성분을 이용한 남성형 탈모 치료제가 개발되었으나 성기능 장애, 간기능 장애 등의 부작용이 있고, 근래의 탈모 발생 원인이 유전적인 요인에 의한 탈모의 비율은 감소하고, 후천적인 다양한 요인의 탈모의 비율이 증가하고 있으므로 탈모 치료가 5α-리덕타제 단일 효소의 저해로는 충분한 효과를 기대하기 어렵다. Testosterone, one of the male hormones, is converted to dihydrotestosterone by the action of an enzyme called 5α-reductase, which is known to promote alopecia. Therefore, it is known that dihydrodestosterone Products that prevent hair loss have been developed through the effect of inhibiting production. From this point of view, although a therapeutic agent for male pattern baldness has been developed using finasteride, which has been used as a treatment for male prostate, there are side effects such as sexual dysfunction and hepatic dysfunction, and the cause of hair loss in recent years is hair loss caused by genetic factors The ratio decreases, and the rate of hair loss of various acquired factors increases. Therefore, it is difficult to expect the hair loss treatment to be effective by the inhibition of 5α-reductase single enzyme.
이와 관련하여, 한국공개특허 제2008-0031583호에서는 녹차, 살구씨, 오미자, 생각 추출액을 포함하는 발모제 조성물이 개시되어 있으며, 한국등록특허 제0929880호에서는 측백나무 잎, 부추뿌리, 뽕나무 잎, 생강 및 검은 콩을 유효성분으로 포함하는 탈모 방지용 조성물이 개시되어 있으나, 아직 탈모를 완벽하게 방지할 수 있는 제품은 나타나지 않고 있는 바, 탈모 방지에 대한 지속적인 연구가 요구되는 실정이다.
In this regard, Korean Patent Publication No. 2008-0031583 discloses a hair growth composition containing green tea, apricot seed, omija, and extract extract. In Korean Patent No. 0929880, And black beans as an active ingredient. However, there are no products that can completely prevent hair loss, and there is a need to continuously study hair loss prevention.
이에 본 발명자는 탈모 방지, 모발성장 촉진, 두피 질환 개선의 효과를 갖는 조성물을 제공하고자, 연구, 노력한 결과, 살구씨, 하수오, 측백엽 및 호두의 생약 추출물과 호두 외과피 추출물 발효액을 혼합하면 우수한 탈모 방지 효과 및 두피질환 치료 효과가 있음을 발견함으로써 본 발명을 완성하게 되었다. Accordingly, the present inventors have made efforts to provide a composition having the effect of preventing hair loss, promoting hair growth, and improving scalp disease. As a result, it has been found that when the herbal extract of apricot seeds, horseradish, And the therapeutic effect of the scalp disease, thereby completing the present invention.
따라서, 본 발명은, 탈모 방지, 모발성장 촉진, 두피 질환 개선 효과를 나타내는 조성물을 제공하는데 그 목적이 있다.
Accordingly, it is an object of the present invention to provide a composition exhibiting hair loss prevention, hair growth promotion, and scalp disease improving effect.
상기 목적을 달성하기 위하여, 본 발명은 살구씨, 하수오, 측백엽 및 호두를 포함하는 생약 추출물과 호두 외과피 추출물 발효액을 포함하는 탈모 방지 및 두피질환 치료용 조성물을 제공한다.In order to achieve the above object, the present invention provides a composition for preventing hair loss and treating scalp disease comprising herbal medicine extracts containing apricot seeds, horseradish, mackerel and walnuts, and a fermentation liquid of walnut suture extract.
본 발명의 바람직한 일 실시예에 있어서, 본 발명의 탈모 방지 및 두피질환 치료용 조성물은 상기 생약 추출물 100 중량부에 대하여 상기 호두 외과피 추출물 발효액 1 ~ 50 중량부를 포함할 수 있다. In a preferred embodiment of the present invention, the composition for preventing hair loss and scalp disease according to the present invention may comprise 1 to 50 parts by weight of the fermentation liquid of the walnut suture extract, based on 100 parts by weight of the herbal medicine extract.
또한, 상기 생약 추출물은 살구씨 100 중량부에 대하여 하수오 30 ~ 50 중량부, 측백엽 50 ~ 80 중량부 및 호두 1 ~ 20 중량부를 포함할 수 있다. In addition, the herbal medicine extract may contain 30 to 50 parts by weight of horseradish, 50 to 80 parts by weight of papaya, and 1 to 20 parts by weight of walnuts, based on 100 parts by weight of apricot seeds.
또한, 상기 생약 추출물은 살구씨 100 중량부에 대하여 한련초 30 ~ 50 중량부를 더 포함할 수 있다. In addition, the herbal medicine extract may further contain 30 to 50 parts by weight per 100 parts by weight of apricot seeds.
또한, 상기 생약 추출물은 살구씨 100 중량부에 대하여 감잎 70 ~ 100 중량부를 더 포함할 수 있다.
The herbal medicine extract may further contain 70 to 100 parts by weight of persimmon leaf to 100 parts by weight of apricot seeds.
본 발명의 조성물은 탈모의 감소 및 지루성 피부염의 증상을 개선하는 효과가 우수하므로, 두피에 나타나는 질환의 치료 등에 널리 적용될 수 있다. 또한 끈적임과 냄새가 상대적으로 적어, 사용자의 거부감을 최소화할 수 있다.
The composition of the present invention is excellent in the effect of alleviating hair loss and improving the symptoms of seborrheic dermatitis, so that it can be widely applied to the treatment of diseases appearing on the scalp. Also, the stickiness and the smell are relatively small, and the user's sense of rejection can be minimized.
이하, 본 발명에 대하여 상세히 설명하기로 한다. 이에 앞서, 본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 아니되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다. 따라서, 본 명세서에 기재된 실시예에 기재된 구성은 본 발명의 가장 바람직한 일 실시예에 불과할 뿐이고 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형예들이 있을 수 있음을 이해하여야 한다.
Hereinafter, the present invention will be described in detail. Prior to this, terms and words used in the present specification and claims should not be construed as limited to ordinary or dictionary terms, and the inventor should appropriately interpret the concepts of the terms appropriately It should be interpreted in accordance with the meaning and concept consistent with the technical idea of the present invention based on the principle that it can be defined. Therefore, the constitutions described in the embodiments described herein are merely the most preferred embodiments of the present invention, and are not intended to represent all of the technical ideas of the present invention. Therefore, various equivalents which can be substituted at the time of application It should be understood that variations can be made.
본 발명의 탈모 방지 및 두피질환 치료용 조성물은 살구씨, 하수오, 측백엽 및 호두를 포함하는 생약 추출물과, 호두 외과피 추출물 발효액을 포함한다.
The composition for preventing hair loss and treating scalp disease of the present invention includes herbal medicine extracts including apricot seeds, horseradish, mulberry leaves and walnuts, and fermentation liquid of walnut suture extract.
상기 살구씨는 살구나무 열매의 씨로서, 상기 살구나무는 각지에서 과수로 재배하는 낙엽소교목으로 수고는 5m 정도 자라고 잎은 어긋나기를 하며 난형 또는 광타원형이다. 잎의 밑은 둥글며 끝은 날카롭고 뾰족하며 가장자리에 날카로운 톱니가 있으며, 꽃은 연분홍색으로 4월에 잎보다 먼저 피며 꽃잎은 둥글며 수술이 많고 암술은 1개다. 살구의 열매는 구형의 핵과이며 융모가 있고, 6월에 황색으로 익는다. 살구씨는 행인이라고도 불리며, 불포화 지방산과 여러 가지 피부에 좋은 성분이 함유되어 있어 잡티 제거 및 주근깨 예방에 효과적이다. 특히, 살구씨의 추출물인 오일은 예로부터 피부 미백에 사용되어 왔으며, 항균 소염 기능이 있어 지성 피부에도 효과적이다.The apricot seed is a seed of an apricot tree, and the apricot tree It is a deciduous arboreous tree cultivated in various places. It grows about 5m in length and its leaves are alternate, ovate or oval. The bottom of the leaf is round, the tip is sharp and sharp, the edge is sharp, the flower is pink, the flower is bloomed in April, the petal is round, the stamen is large, and the pistil is one. The fruit of apricot is spherical nucleus, and there is chorion, and it ripens in yellow in June. Apricot is also known as a passerine, and it contains unsaturated fatty acids and various skin-friendly ingredients, which are effective in preventing dullness and freckles. Especially, the extract oil of apricot seeds has been used for skin whitening since ancient times, and has antibacterial anti-inflammatory function, which is also effective for oily skin.
상기 하수오는 중국원산의 다년생 넝쿨 초본으로서 우리나라의 원야에 자생하고, 주요 성분으로서 안트라퀴노이드로서 크리소파놀, 에모딘, 레인, 사이시온, 크리소파놀, 안트론 등을 함유한다. 또한, 다수의 녹말과 지방, 레시틴을 함유하고, 에모딘과 사이시온 유리형과 배당체형의 두가지 형태로 존재하며, 2,3,4,5'-테트라하이드록시스틸벤-2-0-β-D-글루코시드 등이 함유되어 있다. The Hassuo is a perennial vine of Chinese origin and is native to the wilderness of Korea and contains as main components anthraquinolide such as cresophorol, emodine, lane, cision, crysopanol, anthrone and the like. It also contains a large number of starches, fats and lecithin, and exists in two forms, emodimin and psicin, free and glycoside, and 2,3,4,5'-tetrahydroxystilbene-2-0-0-beta -D-glucoside and the like.
상기 측백엽은 측백나무의 잎으로, 상기 측백나무(側柏, Thujaorientalis)는 측백나무과(Cupressaceae)에 속하는 상록 비늘잎 교목이다. 상기 측백나무의 잎과 가지를 햇볕에 말린 측백엽은 예전부터 한방에서 치습제, 지혈제로 사용되거나 대하증의 치료에 쓰였다. 측백엽에는 주니페르산(juniperic acid), 두존(thujone), 마이우론(mayurone), 사빈산(sabinic acid), 사포닌, 알카로이드 및 비타민 성분 등이 들어있고 청혈, 지혈작용이 있어 혈액을 왕성하게 하는 기능을 가진다. The hyphae are the leaves of a periwinkle tree, and the periwinkle (Thujaorientalis) is an evergreen tree belonging to the Cupressaceae. The leaves and branches of the periwinkle are sun-dried, and the perilla leaf has been used as a moisturizing agent, a hemostatic agent, or in the treatment of large intestine. It contains juniperic acid, thujone, mayurone, sabinic acid, saponin, alkaloids and vitamins, and it has a function of bleeding and haemostasis. .
한편, 호두는 가래나무과의 낙엽교목인 호두나무(Juglans sinensis)의 열매로서, 외과피는 육질로 녹색이며 내과피(핵과:核果)는 매우 단단한 골질로 잘 깨지지 않는다. 핵은 도란형으로 황갈색이며 표면은 봉선을 따라 많은 주름살이 있고 핵 내부는 4실이다. 종자는 2장의 떡잎을 갖춘 것으로 구형에 가까우나 심하게 주름져 있고 백색 또는 담황색을 띠며 그 겉면은 막질의 흑갈색인 종피가 있다. 일반적으로 상기 호두 열매의 핵 내 인(仁)을 식용으로 하는데, 본 발명에서 생약 추출물 내 포함되는 호두는 내과피 내 식용 가능한 핵 부분을 원료로 추출하여 얻은 것을 말한다. On the other hand, walnut is a fruit of walnut tree ( Juglans sinensis ), which is a deciduous tree of the pine tree. Surgical blood is green in meat quality, and the intracranial part is not broken by very hard bone. The nucleus is obovate, yellowish brown, the surface has many wrinkles along the bongline, and there are four inside the nucleus. Seed is composed of two cotyledons, close to spherical shape, very wrinkled, white or pale yellow, and its outer surface is membranous dark brown seed coat. Generally, the nuclei in the nucleus of the walnut fruit are used for edible purposes. In the present invention, the walnut contained in the herbal medicine extract is obtained by extracting an edible nucleus portion in the endosperm as a raw material.
본 발명의 조성물 내 포함되는 생약 추출물은 상기 살구씨, 하수오, 측백엽 및 호두의 추출물을 일 성분으로서 포함하며, 상기 추출물은 물, C1 ~ C10의 탄화수소, C1 ~ C10의 케톤류, C1 ~ C10의 에테르류, C1 ~ C10의 에스테르류, C1 ~ C10의 할로겐화 탄화수소류 및 C1 ~ C10의 알콜류 중에서 선택된 용매를 사용하여 추출함으로써 얻어질 수 있다. 이 때, 상기 살구씨, 하수오, 측백엽 및 호두 원료를 모두 혼합하여 추출한 혼합 추출액을 사용할 수도 있고, 개별적으로 추출한 추출액을 혼합하여 사용할 수도 있다. 상기 추출 용매의 양은 원료 건조 중량의 2 ~ 10 배로 하고, 추출 방법은 중탕 추출, 환류냉각 추출, 초음파 추출 등의 추출 방법을 사용할 수 있으며, 바람직하게는 중탕 추출의 추출방법으로 1회 내지 5회 추출될 수 있다. The herbal medicine extract contained in the composition of the present invention comprises as an ingredient an extract of the above-mentioned apricot seeds, horseradish, mackerel, and walnuts, wherein the extract is selected from the group consisting of water, C 1 to C 10 hydrocarbons, C 1 to C 10 ketones, C 1 and ethers of C 10 acids, by extracting with a solvent selected from halogenated hydrocarbons and alcohols of C 1 to C 10 of the C 1 to C 10 esters, C 1 to C 10 a can be obtained. At this time, a mixed extract obtained by mixing all the raw materials of apricot seeds, seaweed, mackerel, and walnut can be used, or the extracts separately extracted can be mixed and used. The extraction solvent may be 2 to 10 times the dry weight of the raw material, and the extraction method may be an extraction method such as hot water extraction, reflux cooling extraction, ultrasonic extraction, and the like, preferably 1 to 5 times Can be extracted.
또한, 본 발명의 탈모 방지 및 두피질환 치료용 조성물은 호두 외과피 추출물 발효액을 일 구성요소로 포함한다. 호두 외과피 추출물은 손에 묻어나오는 문제가 있으므로, 이를 발효시킨 발효액으로서 본 발며의 조성물 내 포함시키는 것이 요구된다.In addition, the composition for preventing hair loss and treating scalp disease of the present invention comprises a fermentation liquid of a walnut suture extract. Since the extract of walnut scutellum has a problem of being on hand, it is required to include it in the composition of the present invention as a fermentation broth fermented.
상기 호두 외과피 추출물 발효액은 호두 열매 최외곽에 존재하는 외과피의 추출물을 얻은 후, 상기 추출물을 발효하여 제조될 수 있으며, 상기 미생물은 효모(Saccharomyces), 곰팡이류(Aspergillus), 유산균(Lactobacillus) 등The fermentation liquid of the walnut scutellum extract may be prepared by fermenting an extract of a scutellum present in the outermost walnut fruit and then fermenting the extract. The microorganism may be selected from the group consisting of yeast (Saccharomyces), fungi (Aspergillus), lactobacillus
과 같은 일반적으로 발효에 이용되는 종이 사용될 수 있다. 상기 발효는 25 ~ 50℃에서 약 24 ~ 120시간 동안, 바람직하게는 48 ~ 72시간 동안 이루어질 수 있으나, 사용되는 미생물, 사용 원료의 상태에 따라 적절히 조절될 수 있다. Can be used for fermentation. The fermentation can be carried out at 25 to 50 ° C for about 24 to 120 hours, preferably 48 to 72 hours, but can be appropriately controlled depending on the microorganism used and the condition of the raw materials to be used.
상기 본 발명의 탈모 방지 및 두피질환 치료용 조성물은 상기 생약 추출물 100 중량부에 대하여 호두 외과피 추출물 발효액 1 ~ 50 중량부 포함되는 것이 바람직하고, 5 ~ 30 중량부가 포함되는 것이 더욱 바람직하며, 10 ~ 20 중량부가 포함되는 것이 가장 바람직하다. 호두 외과피 추출물 발효액이 상기 범위 미만으로 사용되면 발효액에 의한 탈모 방지 효과 개선을 크게 기대하기 어렵고, 상기 범위를 초과하여 사용되는 경우 탈모 방지의 주 역할을 하는 생약 추출물의 함량이 상대적으로 줄어들어 결과적으로 탈모 방지 효과가 감소하게 된다. The composition for preventing hair loss and scalp disease according to the present invention preferably contains 1 to 50 parts by weight, more preferably 5 to 30 parts by weight, of 10 to 50 parts by weight of the fermentation liquid of the walnut suture extract, per 100 parts by weight of the herbal medicine extract, Most preferably 20 parts by weight. When the fermented broccoli extract of walnuts is used in an amount less than the above range, improvement of the effect of preventing the hair loss by the fermentation broth is not expected to be greatly expected, and when used in excess of the above range, the content of the herbal medicine extract, The prevention effect is reduced.
또한, 상기 생약 추출물은, 살구씨 100 중량부에 대하여 하수오 30 ~ 50 중량부, 측백엽 50 ~ 80 중량부 및 호두 1 ~ 20 중량부를 포함하는 것이 바람직하며, 보다 바람직하게는 하수오 35 ~ 45 중량부, 측백엽 60 ~ 70 중량부 및 호두 5 ~ 10 중량부를 포함하는 것이 좋다 상기 생약 추출물 내 각 성분이 상기 한정된 범위로 포함되는 경우, 각 유효 성분 간의 균형적으로 작용하여 우수한 탈모 방지 및 두피질환 치료 효과를 나타낼 수 있다. In addition, the herbal medicine extract preferably contains 30 to 50 parts by weight of seaweed, 50 to 80 parts by weight of a lateral leaf, and 1 to 20 parts by weight of walnuts, more preferably 35 to 45 parts by weight of seaweed, , 60 to 70 parts by weight of a lateral leaflet, and 5 to 10 parts by weight of walnut. When each ingredient in the herbal medicine extract is included in the above-mentioned limited range, it acts in a balanced manner between each effective ingredient, Lt; / RTI >
또한, 상기 생약 추출물은 한련초를 추가적으로 더 포함할 수 있다. 상기 한련초는 우리나라의 중부와 남부지방의 논두렁, 개울가의 습기가 있는 곳에서 자생하는 다년초 식물로써 애장초, 목한련, 묵두초, 하련초 등으로도 불린다. 한련초에는 사포닌과 탄닌, 고미질, 에크립틴(한련초소), 비타민 A류 물질, 니코틴과 쿠마린 화합물 등이 함유되어 있다. 한련초의 줄기를 자르면 즙이 나와 시간이 지나면 산화되어 까맣게 변색하게 되는데 이는 웨델로락틴이 공기에 산화되어 변색되는 것으로, 옷이나 머리칼, 수염 등의 염색제로도 사용되어 왔다. 상기 한련초는 살구씨 100 중량부에 대하여, 30 ~ 50 중량부가 포함될 수 있으며, 바람직하게는 35 ~ 45 중량부가 포함되는 것이 좋다. In addition, the herbal medicine extract may further include Hansik suk. It is a perennial plant which grows in the wetlands of rice fields and streams in the central and southern parts of Korea. It contains saponin and tannin, gumminess, echulipine (vitamins A), vitamin A, nicotine and coumarin compounds. When the stalk of the hanchukscho is cut off, the juice comes out and becomes oxidized and black color over time. This is because the wedelolactin is oxidized by the oxidation in the air and has been used as a dye for clothes, hair, and hair. It is preferable that 30 to 50 parts by weight, preferably 35 to 45 parts by weight, of the saccharin is included in 100 parts by weight of the apricot seeds.
또한, 상기 생약 추출물은 감잎을 추가적으로 더 포함할 수 있다. 상기 감잎은 감나무(Diospyros Kaki L.)의 잎으로서, 상기 감나무는 높이는 약 6 ~ 14 m, 줄기의 겉껍질은 비늘 모양으로 갈라지며, 작은 가지에 갈색 털이 있다. 상기 감잎은 어긋나고 가죽질이며, 타원형의 달걀 모양으로, 길이 약 7 ~ 17 cm, 너비 약 4 ~ 10 cm로서 톱니는 없고, 잎자루는 길이 5 ~ 15 mm로서 털이 있다. 감잎의 뒷면은 녹색이고 광택이 난다. 상기 감잎은 고혈압, 동맥경화, 심장병 등의 성인병과 위궤양, 십이지장궤양, 당뇨병 등의 만성질환에도 효과가 있고, 암 예방 효과가 있다고 알려진 비타민 A, C, D 및 엽록소를 풍부하게 함유하고 있다. 그 외에도 비타민 B1, 판토텐산, 엽산, 탄닌을 다량 함유하고 있으며, 떫은맛 성분인 탄닌은 여러 가지 생물학적 활성과 함께 독소를 해독하는 작용, 면역기능 부활작용, 활성산소 유리기 소거작용 등이 알려져 있다. 상기 감잎은 살구씨 100 중량부에 대하여 70 ~ 100 중량부가 포함될 수 있으며, 바람직하게는 80 ~ 90 중량부가 포함될 수 있다. In addition, the herbal medicine extract may further include persimmon leaves. The persimmon leaf is a leaf of persimmon ( Diospyros Kaki L.) . The persimmon is about 6 to 14 m in height. The crust of the stem is split into a scaly shape, and brown branches are small branches. The persimmon leaves are oval, oval, oval, about 7 to 17 cm long, about 4 to 10 cm wide, with no sawtooth, petiole is 5 to 15 mm long and has hairs. The back of persimmon leaves is green and glossy. The persimmon leaves are effective against adult diseases such as hypertension, arteriosclerosis and heart disease, chronic diseases such as gastric ulcer, duodenal ulcer and diabetes, and vitamin A, C, D and chlorophyll which are known to have cancer preventive effect. In addition, it contains vitamin B1, pantothenic acid, folic acid, and tannin in large amounts. Tannin, a pungent ingredient, has various biological activities, as well as toxin decryption, immune function, and free radical scavenging. The persimmon leaves may contain 70 to 100 parts by weight, preferably 80 to 90 parts by weight, based on 100 parts by weight of apricot.
상기 본 발명의 탈모 방지 및 두피질환 치료용 조성물은 다양한 형태로 제조될 수 있으며, 일반적인 유화 제형 및 가용화 제형의 화장품 형태로 제조할 수 있다. 유화 제형의 화장품으로는 영양화장수, 크림, 에센스 등이 있으며, 가용화 제형의 화장품으로는 유연화장수가 있다. 또한, 본 발명의 조성물은 화장품 이외에도 피부 과학적으로 허용 가능한 매질 또는 기제를 함유함으로써 피부과학 분야에서 통상적으로 사용되는 국소 적용 또는 전신 적용할 수 있는 보조제 형태로 제조될 수 있다. 적합한 화장품의 제형으로는 예를 들면, 용액, 겔, 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형(리포좀), 비이온형의 소낭 분산제의 형태, 크림, 스킨, 로션, 파우더, 연고, 스프레이 또는 콘실 스틱(conceal stick)의 형태로 제공될 수 있다. 또한, 포말(foam)의 형태 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다.The composition for preventing hair loss and scalp disease according to the present invention may be prepared in various forms, and may be manufactured into cosmetic formulations of general emulsification and solubilization formulations. Cosmetics of emulsified form include nutrition lotion, cream, essence, etc., and cosmetics of solubilized form have softening longevity. In addition, the composition of the present invention can be prepared in the form of an adjuvant which can be applied topically or systemically, which is conventionally used in the field of dermatology by containing a dermatologically acceptable medium or base in addition to cosmetics. Suitable cosmetic formulations include, for example, solutions, gels, solid or kneaded anhydrous products, emulsions obtained by dispersing the oil phase in water, suspensions, microemulsions, microcapsules, microgranules or ionic (liposomes) In the form of a foliar dispersant, in the form of a cream, a skin, a lotion, a powder, an ointment, a spray or a conceal stick. It can also be prepared in the form of a foam or an aerosol composition further containing a compressed propellant.
또한, 본 발명의 조성물은 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온 봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 피부과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. The composition of the present invention can further comprise at least one of a fatty substance, an organic solvent, a solubilizing agent, a thickening agent and a gelling agent, a softening agent, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a perfume, a surfactant, Any other ingredients commonly used in cosmetics, such as nonionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, , ≪ / RTI > and the like.
또한, 본 발명의 조성물을 첨가할 수 있는 제품으로는 스킨로션, 스킨 소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스처 로션, 영양로션, 맛사지크림, 영양크림, 모이스처 크림, 핸드크림, 에센스, 영양에센스, 팩, 비누, 샴푸, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션, 바디클렌저, 유액, 프레스파우더, 루스파우더 등의 제형을 포함한다.
Examples of products to which the composition of the present invention can be added include skin lotions, skin softeners, skin toners, astringents, lotions, milk lotions, moisturizing lotions, nutritional lotions, massage creams, nutritional creams, Nourishing essence, pack, soap, shampoo, cleansing foam, cleansing lotion, cleansing cream, body lotion, body cleanser, latex, press powder, loose powder and the like.
이하, 본 발명을 실시예 및 실험예에 의해 구체적으로 설명하겠는바, 다음 실시예 및 실험예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예 및 실험예에 한정되는 것은 아니다.
Hereinafter, the present invention will be described concretely with reference to Examples and Experimental Examples. However, the following Examples and Experimental Examples are merely illustrative of the present invention, and the present invention is not limited to the following Examples and Experimental Examples.
실시예 1 : 탈모 방지 조성물의 제조Example 1: Preparation of anti-depilation composition
살구씨 100 g, 하수오 40 g , 측백엽 65 g 및 호두(핵) 10 g의 원료에 추출 용매를 첨가해 가며 믹서를 이용하여 2,000 rpm으로 3분간 분쇄하였다. 상기 추출 용매는 에탄올 60 중량%의 수용액을 사용하였다. 상기 추출 용매 600 ml를 가하여 원료 분쇄후 3일간 교반함으로써 1차 추출물을 얻었다.The extraction solvent was added to 100 g of apricot seeds, 40 g of sucrose, 65 g of western white leaf and 10 g of walnut (nucleus), and the mixture was pulverized for 3 minutes at 2,000 rpm using a mixer. As the extraction solvent, an aqueous solution of 60 wt% ethanol was used. 600 ml of the above extraction solvent was added, and the raw material was pulverized and stirred for 3 days to obtain a first extract.
상기 1차 추출물을 정치하여 하층부의 원료를 분리하고, 이에 다시 추출 용매 400 ml를 첨가하여 3일간 교반함으로써 2차 추출물을 얻었다. 상기 2차 추출 혼합물을 거친 여과기(스트레이너)로 원료를 분리 제거하고, 상기 원료가 제거된 2차 추출물을 상기 1차 추출물과 혼합하여 생약 혼합 조성물을 얻었다.
The primary extract was allowed to stand to separate the raw material of the lower layer, and 400 ml of an extraction solvent was further added thereto, followed by stirring for 3 days to obtain a secondary extract. The raw material was separated and removed with a filter (strainer) obtained through the secondary extraction mixture, and the secondary extract from which the raw material was removed was mixed with the primary extract to obtain a herbal composition.
한편, 호두 외과피 20 g을 추출 용매를 첨가해 가며 믹서를 이용하여 2,000 rpm으로 3분간 분쇄하였다. 상기 추출 용매는 에탄올 60 중량%의 수용액을 사용하였다. 상기 추출 용매 60 ml를 가하여 원료 분쇄후 3일간 교반함으로써 1차 추출물을 얻었다. 상기 1차 추출물을 정치하여 하층부의 원료를 분리하고, 이에 다시 추출 용매 60 ml를 첨가하여 3일간 교반함으로써 2차 추출물을 얻었다. 상기 2차 추출 혼합물을 거친 여과기(스트레이너)로 원료를 분리 제거하고, 상기 원료가 제거된 2차 추출물을 상기 1차 추출물과 혼합하여 호두 외과피 추출물을 얻었다. On the other hand, 20 g of walnut suture was pulverized for 3 minutes at 2,000 rpm using a mixer while adding an extraction solvent. As the extraction solvent, an aqueous solution of 60 wt% ethanol was used. 60 ml of the above extraction solvent was added, and the mixture was pulverized and stirred for 3 days to obtain a first extract. The primary extract was allowed to stand to separate the raw material of the lower layer, and 60 ml of an extraction solvent was further added thereto, followed by stirring for 3 days to obtain a secondary extract. The secondary extract mixture was separated and removed with a coarse filter (strainer), and the secondary extract from which the raw material was removed was mixed with the primary extract to obtain a walnut suture extract.
상기 호두 외과피 추출물을 120 ℃에서 20분간 가열하여 잡균을 없애고, 유산균(Lactobacillus fermentum)을 접종하여 40℃에서 48시간 동안 발효키시고, 정밀 여과를 통하여 미생물을 제거하여 호두 외과피 추출물 발효액을 얻었다. The extracts of the walnut scutellariae were heated at 120 ° C for 20 minutes to remove germs, and lactic acid bacteria ( Lactobacillus fermentum ) was inoculated and fermented at 40 ° C for 48 hours. Microorganisms were removed by microfiltration to obtain a walnut suture extract fermentation broth.
상기 생약 혼합 조성물 100 g과 호두 외과피 추출물 발효액 20 g을 정량하여혼합함으로써 최종 탈모 방지 조성물을 제조하였다.
100 g of the crude herbal composition and 20 g of the fermentation liquid of the walnut scutellum extract were weighed and mixed to prepare a final hair loss preventing composition.
실시예 2 : 한련초 포함 탈모 방지 조성물의 제조Example 2: Preparation of Anti Hair Loss Composition Containing Antler
상기 생약 혼합 조성물을 제조함에 있어서, 한련초 40 g을 추가로 첨가한 원료를 사용하는 것을 제외하고는 실시예 1과 동일하게 탈모 방지 조성물을 제조하였다.
In preparing the herbal medicine mixed composition, an anti-hair-loss composition was prepared in the same manner as in Example 1, except that the raw material in which 40 g of persimmon was added.
실시예 3 : 감잎 포함 탈모 방지 조성물의 제조Example 3: Preparation of anti-depilation composition containing persimmon leaves
상기 생약 혼합 조성물을 제조함에 있어서, 감잎 80 g을 추가로 첨가한 원료를 사용하는 것을 제외하고는 실시예 1과 동일하게 탈모 방지 조성물을 제조하였다.
In preparing the herbal medicine composition, an anti-depressant composition was prepared in the same manner as in Example 1 except that 80 g of persimmon leaves were further added.
실험예 1 : 탈모 방지 효과 확인 실험EXPERIMENTAL EXAMPLE 1: Test for confirming hair loss prevention effect
머리 감을때 탈락되는 탈락모를 수집도구로 수집하여 수량을 측정하여, 탈락모의 변화를 관찰하였다. 탈락모의 수집 방법은 머리 감은 물과 행굼에 사용한 물을 직경 30cm이며 높이 20cm의 둥근 통으로 밑면은 거즈로 막혀 물은 통과하고, 탈락모는 통과하지 못하게 하는 도구를 사용하여, 일일 일회 탈락된 모의 개수를 측정하였다.The number of dropouts that were dropped when the hair was wrapped was collected with a collecting tool, and the amount of the drop was measured to observe the change in dropout pattern. The drop-out simulation method is to use the water used for water and rinse in a round tube with a diameter of 30 cm and a height of 20 cm with a gauze on the underside, passing water through the water, Respectively.
피 실험자는 탈모가 급격히 진행된다고 인지하고 있는 사람으로, 대조군은 2명, 시험군은 6명으로 남녀 각 3명씩으로 하였다.The subjects were 2 persons in the control group and 6 persons in the test group, each of 3 men and 3 women.
상기 실시예 1 ~ 3의 조성물을 일 회 5㎖씩 두피에 골고루 분사하여 도포하였고, 일일 도포횟수는 아침, 저녁 2회로 하였다. 또한, 처음 3일간은 증류수를 두피에 도포하여 사용 전 탈락모의 기준을 설정하였고, 4일째부터 추출물을 도포하였다. 조성물의 도포일수는 50일로서, 탈락모는 10일 단위로 측정하였다. The compositions of Examples 1 to 3 were sprayed uniformly onto the scalp 5ml each time, and the number of times of daily application was 2 times in the morning and evening. For the first three days, distilled water was applied to the scalp to set the dropout threshold before use, and the extract was applied on the fourth day. The number of days of application of the composition was 50 days, and decidua was measured in units of 10 days.
한편, 대조군은 추출물 대신 증류수를 하루 2회 도포하였다.On the other hand, the control group applied distilled water twice a day instead of the extract.
하기 표 1에는 실시예 1 ~ 3의 조성물을 도포한 경우 탈락모 수의 평균값을 나타내었다. Table 1 shows the average values of the number of decolorized compounds when the compositions of Examples 1 to 3 were applied.
상기 표 1 에서 보는 바와 같이, 실시예의 탈모 방지용 조성물을 사용 하는 경우, 대조군에 비해 탈락모가 현저하게 감소하였고, 특히 탈락모의 감소는 40일까지 급격하게 나타나다가 이후 완만하게 감소하는 것을 확인할 수 있었다.
As shown in Table 1, when the composition for preventing alopecia of the Example was used, the decolorization was remarkably decreased as compared with the control group. In particular, it was confirmed that the decolorization decreased rapidly until 40 days and thereafter decreased gradually.
실험예 2 : 구진성 발진의 완화 효과 확인 실험Experimental Example 2: Experiment to confirm mitigation effect of oscillatory rash
구진성 발진은 지루성피부염 환자에게서 관찰되는 대표적 증상에 해당한다. 피 실험자는 지루성 피부염의 증상 중 구진성 발진이 있는 사람으로, 대조군은 2명, 시험군은 6명으로 남녀 각 3명씩으로 하였다. Pseudo-rash is a representative symptom observed in patients with seborrheic dermatitis. The subject was a person with acute rash among the symptoms of seborrheic dermatitis, 2 in the control group and 6 in the test group.
상기 실시예 1 ~ 3의 조성물을 일 회 5㎖씩 두피에 골고루 분사하여 도포하였고, 일일 도포횟수는 아침, 저녁 2회로 하였다.The compositions of Examples 1 to 3 were sprayed uniformly onto the scalp 5ml each time, and the number of times of daily application was 2 times in the morning and evening.
조성물의 도포일수는 60일로서, 구진성 발진은 20일 단위로 관찰하였다. The number of days of application of the composition was 60 days, and peak oscillation was observed every 20 days.
한편, 대조군은 추출물 대신 증류수를 하루 2회 도포하였다.On the other hand, the control group applied distilled water twice a day instead of the extract.
하기 표 2에는 실시예 1 ~ 3의 조성물을 도포한 경우 확인된 구진성 발진을 나타내었다. Table 2 below shows the confirmed spherical oscillations when the compositions of Examples 1 to 3 were applied.
상기 표 2에서 보는 바와 같이, 실시예 1 ~ 3의 조성물은 지루성피부염 환자의 두피에 발생하는 구진성 발진을 완화시키며, 구진성 발진은 조성물의 사용 20일째인 초기부터 현저히 감소하여, 60일까지 꾸준히 완화되는 것을 확인할 수 있었다. As shown in the above Table 2, the compositions of Examples 1 to 3 alleviate the petechial oscillations that occur in the scalp of patients with seborrheic dermatitis, and the petechial oscillations decrease markedly from the early 20th day of use of the composition, It was confirmed that it was steadily eased.
상기 구진성 발진은 피지의 과잉 생산, 피지의 배출 불량, 및 유해 미생물의 번식을 통해 발생하는 바, 본 발명의 조성물은 이를 해소하여 완화한 것으로 예상할 수 있다.
The pseudo-oscillation occurs through excessive production of sebum, bad discharge of sebum, and propagation of harmful microorganisms, and the composition of the present invention can be expected to alleviate it by alleviating it.
이상에서는 본 발명의 실시예를 중심으로 설명하였으나, 이는 예시적인 것에 불과하며, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 기술자라면 이로부터 다양한 변형 및 균등한 타 실시예가 가능하다는 점을 이해할 것이다. 따라서 본 발명의 진정한 기술적 보호범위는 이하에 기재되는 특허청구범위에 의해서 판단되어야 할 것이다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed embodiments, but, on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims. . Accordingly, the true scope of the present invention is to be determined by the following claims.
Claims (5)
호두 외과피 추출물 발효액을 포함하는 것을 특징으로 하는 탈모 방지 및 두피질환 치료용 조성물.
Herbal medicine extracts including apricot seeds, daphnia magna, mackerel leaves and walnuts,
A composition for preventing hair loss and treating a scalp disease, which comprises a fermentation liquid of a walnut surgical sphincter extract.
상기 조성물은 생약 추출물 100 중량부에 대하여 호두 외과피 추출물 발효액 1 ~ 50 중량부를 포함하는 것을 특징으로 하는 탈모 방지 및 두피질환 치료용 조성물.
The method according to claim 1,
Wherein the composition comprises 1 to 50 parts by weight of a fermentation liquid of a walnut slice extract according to 100 parts by weight of a crude drug extract.
상기 생약 추출물은 살구씨 100 중량부에 대하여 하수오 30 ~ 50 중량부, 측백엽 50 ~ 80 중량부 및 호두 1 ~ 20 중량부를 포함하는 것을 특징으로 하는 탈모 방지 및 두피질환 치료용 조성물.
The method according to claim 1,
Wherein the herbal medicine extract comprises 30 to 50 parts by weight of horseradish, 50 to 80 parts by weight of leaves, and 1 to 20 parts by weight of walnuts in relation to 100 parts by weight of apricot seeds.
상기 생약 추출물은 살구씨 100 중량부에 대하여 한련초 30 ~ 50 중량부를 더 포함하는 것을 특징으로 하는 탈모 방지 및 두피질환 치료용 조성물.
The method according to claim 1,
Wherein the herbal medicine extract further comprises 30 to 50 parts by weight per 100 parts by weight of apricot seeds.
상기 생약 추출물은 살구씨 100 중량부에 대하여 감잎 70 ~ 100 중량부를 더 포함하는 것을 특징으로 하는 탈모 방지 및 두피질환 치료용 조성물.The method according to claim 1,
Wherein the herbal medicine extract further comprises 70 to 100 parts by weight of persimmon leaves per 100 parts by weight of apricot seeds.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130133649A KR20150051751A (en) | 2013-11-05 | 2013-11-05 | Composition for treating hair or scalp to prevent hair loss |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130133649A KR20150051751A (en) | 2013-11-05 | 2013-11-05 | Composition for treating hair or scalp to prevent hair loss |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20150051751A true KR20150051751A (en) | 2015-05-13 |
Family
ID=53389152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130133649A KR20150051751A (en) | 2013-11-05 | 2013-11-05 | Composition for treating hair or scalp to prevent hair loss |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20150051751A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105055573A (en) * | 2015-07-26 | 2015-11-18 | 四川金堂海纳生物医药技术研究所 | Internal medicine for treating acute lumbar sprain and preparation method internal medicine |
KR20190087863A (en) * | 2018-01-17 | 2019-07-25 | 주식회사 네이처프론트 | Composition for washing hair and scalp to prevent hair losing and to promote hair growth and method for preparing the same |
-
2013
- 2013-11-05 KR KR1020130133649A patent/KR20150051751A/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105055573A (en) * | 2015-07-26 | 2015-11-18 | 四川金堂海纳生物医药技术研究所 | Internal medicine for treating acute lumbar sprain and preparation method internal medicine |
KR20190087863A (en) * | 2018-01-17 | 2019-07-25 | 주식회사 네이처프론트 | Composition for washing hair and scalp to prevent hair losing and to promote hair growth and method for preparing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3415198B2 (en) | External preparation for skin | |
KR20130023326A (en) | Cosmetic composition containing the sargassum fulvellum, gelidium cartilagineum and hixikia fusiforme okamura extracts | |
KR101387308B1 (en) | Skin whitening composition by using of dendropanax morbifera ferment extract | |
KR101896908B1 (en) | Method for preparing camellia infused oil and cosmetic composition comprising the same | |
KR101800213B1 (en) | Skin Whitening Cosmetic Composition Containing Extracts of Acer barbinerve Max., Acer barbinervis var. glabrescens or Acer tschonoskii var. rubripes | |
CN107412031B (en) | Skin external composition containing hesperetin | |
KR101350292B1 (en) | Cosmetic composition containing fermented extracts of panax ginseng root, ganoderma lucidum and white tea and method for preparing the same | |
KR101686008B1 (en) | Composition comprising extract of herbal mixture for preventing alopecia or hair growth effect | |
KR20140145278A (en) | Cosmetic composition containing Cimicifuga heracleifolia extract, Cornus officinalis extract and Geranium nepalense extract for skin convergence and elasticity effect | |
KR101189838B1 (en) | Composition for improving condition of hair and scalp containing fermented plant extracts | |
KR101829891B1 (en) | A cosmetic composition comprising osmanthus asiaticus extract and clematis apiifolia extract | |
TW201615203A (en) | Composition for preventing hair loss or accelerating hair growth comprising Artemisia umbelliformis extract | |
KR102257448B1 (en) | Cosmetic composition containing black kelp | |
KR101969684B1 (en) | A cosmetic composition for anti-wrinkle and skin pore reduction containing natural spicule powder and natural complex extract | |
KR20150051751A (en) | Composition for treating hair or scalp to prevent hair loss | |
KR20130066466A (en) | Cosmetic composition comprising the mixed extracts of achillea, borage, helichrysum, lady's mantle, and eucalyptus | |
KR102205789B1 (en) | Extermal composition for preventing hair loss containing extracts derived from natural products and method for manufacturing the same | |
KR102679345B1 (en) | Composition for preventing alopecia or promoting hair growth | |
KR20160043698A (en) | Composition for treating hair or scalp to prevent hair loss | |
KR102386118B1 (en) | Composition comprising Lespedeza plant extracts for skin volume augmentation | |
KR20190078077A (en) | Hair cosmetic composition containing sprout complex extracts | |
KR20130023324A (en) | Cosmetic composition comprising of the mixed herb fermentation extracts | |
KR20170107943A (en) | Skin Whitening Cosmetic Composition Containing Extracts of Wikstroemia trichotoma | |
KR102076179B1 (en) | A cosmetic composition for alleviating skin irritation by vitamin c containing a mixed extract of iris lactea and doellingeria scabra | |
KR102076655B1 (en) | A cosmetic composition for slimming containing spicule powder and curcuma longa extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20131105 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20150304 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20151008 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20150304 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |